Centogene N.V., a leading biotechnology company headquartered in Germany, is at the forefront of genetic diagnostics and data-driven healthcare solutions. Founded in 2006, Centogene has established itself as a key player in the rare disease and genetic testing sectors, with a strong operational presence across Europe, North America, and Asia. The company specialises in providing comprehensive genomic analysis and innovative diagnostic services, uniquely leveraging its extensive biobank and proprietary data platform. Centogene's core offerings include genetic testing for rare diseases, which are distinguished by their high accuracy and rapid turnaround times. With a commitment to advancing precision medicine, Centogene has achieved significant milestones, including partnerships with major pharmaceutical companies and contributions to global research initiatives. Its position in the market is underscored by a robust portfolio of intellectual property and a reputation for excellence in genetic diagnostics.
How does Centogene N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Centogene N.V.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Centogene N.V., headquartered in Germany (DE), currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As of now, Centogene N.V. does not inherit emissions data from a parent company or related organisation, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the industry context. In summary, Centogene N.V. has yet to disclose its carbon emissions or set formal climate commitments, leaving a gap in understanding its environmental impact and sustainability efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Centogene N.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
